CAT vs LAB · P/E 48, rev $20.54B vs rev $174.4M
Caterpillar Inc (CAT) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CAT and LAB stock pages for the full models.
Not investment advice.